Caption Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.83M Buy
350,000
+330,000
+1,650% +$8.79M 0.06% 345
2025
Q4
$498K Hold
20,000
﹤0.01% 1244
2025
Q3
$510K Hold
20,000
﹤0.01% 1296
2025
Q2
$485K Hold
20,000
0.01% 1118
2025
Q1
$507K Sell
20,000
-756,800
-97% -$19.8M ﹤0.01% 1100
2024
Q4
$20.6M Buy
776,800
+291,800
+60% +$7.92M 0.19% 78
2024
Q3
$14M Sell
485,000
-190,700
-28% -$5.56M 0.22% 108
2024
Q2
$18.9M Buy
675,700
+375,700
+125% +$10.3M 0.29% 73
2024
Q1
$8.32M Buy
300,000
+150,000
+100% +$4.16M 0.13% 203
2023
Q4
$4.32M Buy
+150,000
New +$4.53M 0.06% 382
2023
Q1
Sell
-172,400
Closed -$8.83M 1436
2022
Q4
$8.83M Hold
172,400
0.14% 181
2022
Q3
$7.54M Buy
+172,400
New +$8.38M 0.1% 231
2021
Q3
Sell
-250,000
Closed -$9.79M 1723
2021
Q2
$9.79M Buy
+250,000
New +$9.72M 0.13% 196
2020
Q4
Sell
-737,800
Closed -$25.7M 1190
2020
Q3
$25.7M Buy
+737,800
New +$25.9M 0.6% 20

Other funds holding PFE

Caption Management's PFE Position: Q1 2026 in Review

Caption Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 134,800 shares — an estimated $3.59M sold.

Caption Management first reported a position in PFE in Q3 2020 and held it in 7 quarters. The position peaked at $13.7M in Q3 2020. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Caption Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 134,800 Pfizer shares in Q1 2026, an estimated $3.59M.
  • Caption Management first reported a position in Pfizer in Q3 2020 and held it in 7 quarters.
  • Caption Management's Pfizer position peaked at $13.7M in Q3 2020.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.